2 reports

  • R&D Progress

NA : Not Available Source: Global Markets Direct DRUGS TO INHIBIT SIRT## FOR ISCHEMIC STROKE AND MYOCARDIAL INFARCTION - DRUG PROFILE DS-## - DRUG PROFILE EP-## - DRUG PROFILE EPGN-## - DRUG PROFILE EPOETIN ALFA - DRUG PROFILE FILGRASTIM - DRUG PROFILE Drug Name Company/ Institute

  • Neurological Disorder
  • Stem Cell
  • United States
  • Company
  • Product Initiative

Hoffmann-La Roche Ltd ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Gilead Sciences Inc ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## Bristol-Myers Squi

  • Clinical Trial
  • Leukemia
  • Stem Cell
  • World
  • Product Initiative